As Drug Risks Mount, Senators Put Pressure On FDA
The proposed bill, sponsored by Senators Edward M. Kennedy (D-Mass.) and Michael B. Enzi (R-Wyo.), would generate extra funding for the agency, in part by creating higher fines for drug companies that fail to follow through on safety studies after drugs have hit the market.
In addition, the bill would allow the...
To view the full article, register now.